x

Posted 12 September, 2023

Hamilton Lane INC appointed Erik Hirsch as new CEO

Nasdaq:HLNE appointed new Chief Executive Officer Erik Hirsch in a 8-K filed on 12 September, 2023.


  On the same day, the Board appointed Erik Hirsch and Juan Delgado-Moreira as co-Chief Executive Officers, also effective as of January 1, 2024.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Hamilton Lane INC
Financial Services • Investment Advisors
Hamilton Lane, Inc. is a holding company, which engages in the provision of private markets investment solutions. The firm works with clients to conceive, structure, build out, manage, and monitor portfolios of private markets funds and direct investments. It also offers the following solutions: customized separate accounts, specialized funds, advisory services, distribution management, and reporting, monitoring, data, and analytics. The company was founded in 1991 and is headquartered in Conshohocken, PA.
Market Cap
$6.09B
View Company Details
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On September 7, 2023, Mario Giannini, the Chief Executive Officer ("CEO") of Hamilton Lane Incorporated (the "Company"), provided notice to the Board of Directors of the Company (the "Board") that he is transitioning away from his position as CEO, effective as of January 1, 2024, as part of the Company's long-term succession planning process. He will stay on with the Company as an employee and will join Hartley Rogers as Executive Co-Chairman, also effective as of January 1, 2024. Mr. Giannini will also continue to serve in his capacity as a director of the Company.


On the same day, the Board appointed Erik Hirsch and Juan Delgado-Moreira as co-Chief Executive Officers, also effective as of January 1, 2024. Please see the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on July 25, 2023 (the "Proxy Statement"), under the headings "Proposal No. 1-Election of Directors" and "Executive Officers", for the background and experience of Messrs. Hirsch and Delgado-Moreira, which are incorporated by reference herein. When they begin their new roles, Mr. Delgado-Moreira will lead the Company's global sales efforts and client service organization, while Mr. Hirsch will lead the Company's strategic direction and manage its operations. They will jointly manage the Company's global investment team.


In addition, at its meeting on September 7, 2023, the Board increased the size of the Board from seven directors to nine directors and unanimously elected Mr. Delgado-Moreira as a Class I director of the Company to fill one of the resulting vacancies, effective as of January 1, 2024. His initial term will expire at the Company's 2026 annual meeting of stockholders. As of the date hereof, the Board has not determined any committee appointments for Mr. Delgado-Moreira. The Company is currently a party to a stockholders agreement with certain significant outside investors, members of management and significant employee stockholders pursuant to which the Company's controlling stockholder, HLA Investments, LLC ("HLAI"), has the right to designate individuals to fill Board vacancies. HLAI designated Mr. Delgado-Moreira as director. HLAI is controlled by Mr. Rogers. The Board, in consultation with HLAI, is conducting a search for an independent director to fill the remaining vacancy. 


The Company has not yet made any determination with respect to changing the compensation of Messrs. Giannini, Hirsch or Delgado-Moreira.


There are no arrangements or understandings between either of Messrs. Hirsch or Delgado-Moreira and any other persons or entities pursuant to which either have been appointed as a co-CEO, and there is no family relationship between either of them and any directors or executive officers of the Company or any person nominated or chosen to become a director or executive officer. Neither has currently engaged, and has not since the beginning of fiscal 2023 been engaged, in any transactions with the Company or its subsidiaries that are required to be disclosed under Item 404(a) of Regulation S-K, except for the following:


-As significant pre-initial public offering ("IPO") owners of HLA, Messrs. Hirsch and Delgado-Moreira are each a party to the Company's stockholders agreement, and Mr. Hirsch is a party to the Company's tax receivable agreement and exchange agreement, with respect to their continuing ownership interest in the Company. These agreements are described in detail in the Company's Proxy Statement, and Messrs. Hirsch and Delgado-Moreira participate on the same terms as other similarly situated members of senior management.


-As previously disclosed, pre-IPO owners of HLA, including certain directors, executive officers and beneficial owners, receive periodic payments under the tax receivable agreement. Since the beginning of the Company's 2023 fiscal year, Mr. Hirsch received a payment under the tax receivable agreement of $1,314,022.


-Also as previously disclosed, certain of the Company's employees are permitted to invest their own capital in the Company's funds alongside its clients and redeem such investments in accordance with the terms of the fund. As of the date hereof, the aggregate amount that Messrs. Hirsch and Delgado-Moreira have been authorized to invest is $3,000,000 and $34,000,000, respectively.


-As parties to the stockholders agreement, Messrs. Hirsch and Delgado-Moreira have each agreed to vote all shares of the Company's voting stock, including Class A common stock and Class B common stock, in the manner directed by HLAI on all matters submitted to a vote of the Company's stockholders. Due to the aggregate voting 


power of HLAI, it is able to exercise control over all matters requiring stockholders' approval, including the election of directors and any significant corporate transactions.


Messrs. Hirsch and Delgado-Moreira have each previously signed the Company's form of confidentiality and non-disclosure agreement and the Company's standard form of indemnification agreement.